Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
CommonHealth Recovery, located in Frankfort, KY, provides extensive treatment for substance use disorders and dedicated services for those facing co-occurring mental health and substance use challenges. The facility features intensive outpatient programs, standard outpatient care, and medication-assisted treatment options including methadone, buprenorphine, or naltrexone. Their approach emphasizes anger management, brief intervention strategies, and cognitive behavioral therapy, serving adult men and women, as well as survivors of intimate partner violence. CommonHealth Recovery offers personalized, high-standard care for adults and young adults of any gender, promoting lasting recovery and overall wellness.
Situated in Great Barrington, MA, Commonwealth Collaborative delivers an extensive array of treatment services for substance misuse, catering to both adults and children. The center addresses the needs of individuals grappling with concurrent severe mental health disorders. They offer intensive outpatient care, outpatient day treatment, and partial hospitalization alternatives. Emphasizing techniques such as 12-step facilitation, anger management, and brief interventions, the facility customizes its approach to suit each person’s unique circumstances. Commonwealth Collaborative features dedicated programs for adolescents, adult males, and adult females. With a commitment to providing effective treatment for all genders, this center supports individuals on their journey to recovery and wellness.
Communicare Outpatient Clinic in Leitchfield, Kentucky provides intensive and regular outpatient addiction treatment with buprenorphine or naltrexone for children, adolescents, young adults, and seniors. Criminal justice clients and people with co-occurring mental illness are served. Medicare, Medicaid, private insurance, and a sliding fee scale are accepted.
Community Action Against Addiction, based in Cleveland, OH, provides extensive treatment for substance use disorders through multiple formats such as intensive outpatient, outpatient, and medication-assisted therapies using methadone, buprenorphine, or naltrexone. The center focuses on personalized treatment plans that incorporate methods like cognitive behavioral therapy, anger management, and the Matrix Model. Specialized programs are designed for adult men, adult women, and individuals who have faced intimate partner or domestic violence. Catering to both adult and young adult populations, this facility prioritizes delivering effective care to assist individuals in their recovery journey.
Regular and intensive outpatient treatment with buprenorphine and naltrexone is offered in Gering, Nebraska, for children, adolescents, young adults, and seniors with substance use or co-occurring disorders. Medicare, Medicaid, and SAMHSA block grants are accepted, a sliding fee scale and payment assistance are available, and services are provided in Spanish.
Commitment House LLC, located in Elizabethtown, KY, delivers expert care for adult women facing addiction and concurrent serious mental health challenges. The program features intensive outpatient, outpatient, and day treatment modalities, employing proven methods such as 12-step facilitation, brief intervention, and cognitive behavioral therapy. Designed specifically for adult women of all ages, including older adults, seniors, and younger adults, the center is dedicated to high-quality, individualized recovery plans, making it a prime option for those pursuing thorough and personalized rehabilitation.
At Commonwealth Counseling Centers in Prestonsburg, KY, we provide a full spectrum of care for adults and young adults struggling with addiction. Our expertise extends to treating co-occurring substance use disorders and severe mental health conditions in adults, alongside emotional challenges in children. We offer robust intensive outpatient and standard outpatient services, incorporating medications like methadone, buprenorphine, and naltrexone. Our therapeutic framework includes 12-step facilitation, anger management, and brief intervention strategies. We proudly serve active duty military, adult men, and women, ensuring that both genders receive tailored, high-quality support for addiction and dual diagnoses.
CommQuest Services Inc, located in Canton, OH, provides extensive addiction recovery programs for individuals of all ages. Their expertise encompasses withdrawal management, comprehensive substance abuse care, and dual diagnosis treatment. They offer structured intensive outpatient, standard outpatient, and outpatient detoxification options. Through therapeutic approaches such as anger management, cognitive behavioral techniques, and motivational interviewing, patients receive individualized support. The center is notably equipped to serve specific populations including those involved with the justice system, military households, and veterans. CommQuest Services Inc is dedicated to delivering effective, research-supported treatment for both addiction and co-occurring mental health conditions for all genders.
Situated in Sardis, MS, Communicare is a fully-equipped rehabilitation facility that delivers targeted treatment options for substance abuse and concurrent mental health issues affecting both adults and children. The center offers a variety of services, including intensive outpatient programs, standard outpatient care, and treatments with methadone, buprenorphine, or naltrexone. Emphasizing techniques such as 12-step guidance, anger management, and short-term intervention strategies, Communicare addresses the needs of teenagers and individuals dealing with trauma, intimate partner abuse, and domestic violence. With a commitment to high-quality care, the center formulates personalized treatment strategies for adults and seniors across all gender identities to foster sustainable recovery.
Communities of Recovery Inc in Branson, MO, delivers a variety of scientifically-backed therapies for addiction. The center offers extended, brief, and immediate residential services, utilizing methods including 12-step integration, cognitive behavioral therapy, and contingency management. Featuring tailored programs for adult males, adult females, and younger adults, this establishment serves various demographics. Its dedication to personalized treatment and complete assistance distinguishes this facility, providing excellent care for individuals pursuing recovery. Regardless of your age or gender, Communities of Recovery Inc is dedicated to aiding your path to abstinence.
Situated in Senatobia, MS, Communicare specializes in outpatient care for adults facing substance misuse and co-occurring mental health issues, as well as for children experiencing significant emotional difficulties. The center offers a variety of services, including outpatient treatment options like methadone or buprenorphine and naltrexone therapies, 12-step programs, anger management, and short-term intervention strategies. With an emphasis on distinct groups such as teens, those who have encountered trauma or domestic violence, and individuals impacted by intimate partner violence, Communicare provides customized support for each person. Catering to adults and seniors of all genders, this establishment is dedicated to offering exceptional, personalized care aimed at fostering enduring recovery.
Communicare, situated in Oxford, MS, is a multifaceted rehabilitation facility that specializes in addressing substance use issues along with accompanying mental health challenges in both adults and children. The center offers a variety of treatment options, such as intensive outpatient programs, standard outpatient services, and medication-assisted therapies like methadone, buprenorphine, and naltrexone. Employing research-backed methodologies, Communicare provides support through 12-step programs, anger management courses, and brief interventions. The center features distinctive programs aimed at adolescents, those affected by intimate partner or domestic violence, and individuals who have experienced trauma. With dedicated services designed for adults and seniors of diverse backgrounds, Communicare is committed to delivering personalized care and support for every individual.
Situated in Oxford, MS, Communicare provides an array of specialized treatment options designed for both adults and young adults facing challenges related to substance use and concurrent mental health conditions. The center offers a variety of services, including hospital inpatient detoxification and around-the-clock hospital inpatient care, delivering thorough support for those on their journey to recovery. By employing strategies such as 12-step facilitation and anger management, Communicare customizes its treatment plans to align with the specific needs of each client. Additionally, the center features distinct programs for active duty military personnel, as well as for adult men and women, ensuring a tailored approach to care. With an emphasis on high-quality and individualized treatment, Communicare is committed to assisting individuals in achieving enduring sobriety and overall wellness.
Situated in Pittsboro, MS, Communicare specializes in providing outpatient care for individuals dealing with substance abuse and co-occurring mental health issues, serving both adults and children. The center focuses on customized treatment plans for those who have faced trauma or domestic violence, fostering a nurturing atmosphere for recovery. Employing methods like 12-step support and anger management techniques, Communicare prioritizes personalized attention for each client. Their offerings include outpatient treatments with methadone/buprenorphine and specific interventions for older adults. Moreover, they feature tailored programs for teenagers, accommodating a broad spectrum of needs. The facility also implements gender-specific services for men and women to ensure a more tailored therapeutic journey.
Communicare, located in Holly Springs, MS, provides a variety of outpatient treatment options that address issues related to substance use, co-occurring disorders, and traumatic experiences. The center is particularly adept at dealing with intimate partner violence, domestic abuse, and trauma recovery, and it serves adults and seniors of all genders. The treatment methodologies implemented include 12-step programs, anger management, and short-term interventions. With a special emphasis on adolescents and those facing serious mental health challenges, Communicare ensures effective care through outpatient services, including methadone/buprenorphine or naltrexone therapies. This facility is committed to guiding clients through their recovery process with tailored and thorough support.
Communicare, situated in Water Valley, MS, delivers outpatient care for individuals of all ages struggling with substance use disorders, particularly those also experiencing mental health concerns. The facility distinguishes itself with targeted interventions for teens, survivors of domestic abuse and trauma, and caters to both male and female clientele. Their therapeutic modalities encompass 12-step support, anger resolution techniques, and concise counseling strategies. Prioritizing effective treatment, Communicare also administers outpatient medication-assisted treatment, including methadone, buprenorphine, or naltrexone. Their services are designed to comprehensively address the recovery needs of adults and older adults grappling with addiction and psychological well-being.
Communicare Inc, located in Elizabethtown, KY, provides an extensive selection of outpatient programs aimed at addressing substance use and concurrent mental health challenges in adults, as well as emotional issues in children. Their offerings encompass 12-step support, anger management sessions, and short-term interventions. This center serves diverse groups, such as active duty military members, teenagers, adult males and females, and seniors. Emphasizing personalized care and tailored treatment approaches, Communicare Inc aims to deliver specialized assistance to aid individuals on their journey to recovery.
Communicare Inc, located in Elizabethtown, KY, provides targeted treatment for substance use disorders alongside mental health services for both adults and children. This facility features residential and short-term accommodations and offers methods such as 12-step facilitation, anger management, and brief intervention strategies. The center has distinct programs designed for adult women, particularly those who have experienced intimate partner violence, domestic violence, or sexual abuse. Catering specifically to females, it serves a broad range of individuals, including adults, seniors, and young adults. With a commitment to quality care and personalized treatment plans, this center stands out as a caring option for individuals looking to recover from addiction and traumatic experiences.
Communicare Inc, located in Elizabethtown, KY, delivers a wide spectrum of addiction recovery services specifically for adult women. The center features intensive outpatient, long-term residential, and standard outpatient options, all grounded in evidence-based methods, including 12-step programs, anger management techniques, and cognitive behavioral therapy. There are targeted initiatives for those who have faced trauma, domestic violence, or intimate partner violence. By addressing both substance abuse and significant mental health challenges, Communicare Inc provides individualized support to women of all ages, ensuring high-quality care for its clients.
Communities of Recovery Inc in Springfield, MO, delivers thorough addiction recovery services, emphasizing extended stays in a residential setting. The center provides structured living environments, including transitional housing, halfway house accommodations, and sober living arrangements, specifically designed for adult men, adult women, and young adults. Through evidence-based methods such as 12-step facilitation, cognitive behavioral therapy, and motivational interviewing, the program supports individuals of all genders on their path to recovery. Dedicated to the unique needs of young adults, this facility ensures personalized treatment plans for every resident. Communities of Recovery Inc is distinguished by its effective treatment strategies and dedication to fostering sustained abstinence.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.